Literature DB >> 1293389

Bone marrow transplantation for Niemann-Pick type IA disease.

E Bayever1, N Kamani, P Ferreira, G A Machin, M Yudkoff, K Conard, M Palmieri, J Radcliffe, D A Wenger, C S August.   

Abstract

Bone marrow transplantation has been undertaken with encouraging results as therapy for a wide variety of lysosomal storage diseases. We report a case of Niemann-Pick disease Type IA in which, despite the presence of only mild hypotonia with depressed reflexes, the clinical course of the disease appeared to be only slightly modified by this procedure, which was performed at the earliest practical opportunity. The patient was diagnosed early when asymptomatic, because of a family history of an affected sibling who died at 14 months. He received a bone marrow transplant from an HLA-identical, MLC non-reactive sibling donor, whose leukocyte sphingomyelinase activity was in the homozygote normal range. There was adequate engraftment as evidenced by persistently normal leukocyte sphingomyelinase activities, and there was no evidence of graft-versus-host disease. Visceral storage and neurological impairment were less rapidly progressive than in his untreated sibling but he eventually died at 30 months. Autopsy confirmed that this was essentially due to the effects of the underlying Niemann-Pick disease. We conclude that despite some success in other neurovisceral lysosomal storage disorders, bone marrow transplantation is not likely to be an adequate treatment for Niemann-Pick disease Type IA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1293389     DOI: 10.1007/bf01800234

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  25 in total

Review 1.  Human gene therapy.

Authors:  W F Anderson
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

2.  Bone marrow transplantation for metabolic disorders at Huddinge Hospital.

Authors:  O Ringdén; C G Groth; J Aschan; P Bolme; P Ljungman; B Lönnqvist; G Malm; J E Månsson; A Shanwell; L Svennerholm
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation.

Authors:  P M Hoogerbrugge; K Suzuki; K Suzuki; B J Poorthuis; T Kobayashi; G Wagemaker; D W van Bekkum
Journal:  Science       Date:  1988-02-26       Impact factor: 47.728

4.  Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography.

Authors:  S B Heymsfield; T Fulenwider; B Nordlinger; R Barlow; P Sones; M Kutner
Journal:  Ann Intern Med       Date:  1979-02       Impact factor: 25.391

5.  Blood glucosylceramide levels in Gaucher's disease and its distribution amongst lipoprotein fractions.

Authors:  G Dawson; J Y Oh
Journal:  Clin Chim Acta       Date:  1977-02-15       Impact factor: 3.786

6.  Bone marrow transplantation for Niemann-Pick mice.

Authors:  T Sakiyama; M Tsuda; M Owada; K Joh; S Miyawaki; T Kitagawa
Journal:  Biochem Biophys Res Commun       Date:  1983-06-15       Impact factor: 3.575

7.  In situ degradation of sphingomyelin by cultured normal fibroblasts and fibroblasts from patients with Niemann-Pick disease type A and C.

Authors:  J C Maziere; C Maziere; L Mora; J D Routier; J Polonovski
Journal:  Biochem Biophys Res Commun       Date:  1982-10-15       Impact factor: 3.575

8.  Direct evidence for a bone marrow origin of the alveolar macrophage in man.

Authors:  E D Thomas; R E Ramberg; G E Sale; R S Sparkes; D W Golde
Journal:  Science       Date:  1976-06-04       Impact factor: 47.728

9.  Allogeneic bone marrow-plus-liver transplantation in the C57BL/KsJ spm/spm mouse, an animal model of Niemann-Pick disease.

Authors:  R Yasumizu; S Miyawaki; K Sugiura; T Nakamura; Y Ohnishi; R A Good; Y Hamashima; S Ikehara
Journal:  Transplantation       Date:  1990-04       Impact factor: 4.939

10.  Treatment of Niemann-Pick disease type B by allogeneic bone marrow transplantation.

Authors:  A Vellodi; J R Hobbs; N M O'Donnell; B S Coulter; K Hugh-Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-28
View more
  6 in total

1.  Construction of eukaryotic expression vector pBlacz and its expression both in vitro and in vivo.

Authors:  S Qu; S Yang; Y You; S Liu; S He
Journal:  J Tongji Med Univ       Date:  1996

2.  Lysosomal Storage Diseases.

Authors:  Edward M. Kaye
Journal:  Curr Treat Options Neurol       Date:  2001-05       Impact factor: 3.598

3.  Characterization of common SMPD1 mutations causing types A and B Niemann-Pick disease and generation of mutation-specific mouse models.

Authors:  Iwan Jones; Xingxuan He; Fourogh Katouzian; Peter I Darroch; Edward H Schuchman
Journal:  Mol Genet Metab       Date:  2008-09-23       Impact factor: 4.797

Review 4.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

5.  Niemann-Pick disease: sixteen-year follow-up of allogeneic bone marrow transplantation in a type B variant.

Authors:  S Victor; J B S Coulter; G T N Besley; I Ellis; R J Desnick; E H Schuchman; A Vellodi
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

6.  Autopsy pathology of infantile neurovisceral ASMD (Niemann-Pick Disease type A): Clinicopathologic correlations of a case report.

Authors:  Beth L Thurberg
Journal:  Mol Genet Metab Rep       Date:  2020-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.